This is the authors' abstract. We don't add key points for this paper.
Deletion of the long arm of chromosome 11 (11q deletion) is one of the most frequent events that occur during the development of aggressive neuroblastoma. Clinically, 11q deletion is associated with higher disease stage and decreased survival probability. During the last 25 years, extensive efforts have been invested to identify the precise frequency of 11q aberrations in neuroblastoma, the recurrently involved genes, and to understand the molecular mechanisms of 11q deletion, but definitive answers are still unclear. In this review, it is our intent to compile and review the evidence acquired to date on 11q deletion in neuroblastoma.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Mlakar et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: